Pharmaceutical Manufacturer Agrees to Pay to Resolve Allegations

PHILADELPHIA (STL.News) Acting United States Attorney Jennifer Arbittier Williams announced that Incyte Corporation, headquartered in Delaware, has agreed to pay $12.6 million to resolve allegations that it violated the False Claims Act by using a foundation as a conduit to pay the copays of Medicare and TRICARE patients taking Incyte's drug Jakafi. TRICARE is the health care program for uniformed service members, retirees, and their families.